Clinical Trials | September 18, 2025
AstraZeneca's Saphnelo succeeds in Phase III as self-injectable lupus treatment
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
The TULIP-SC trial investigated the efficacy and safety of subcutaneous Saphnelo
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
The state-of-the-art facility is a 450-bedded, multi-specialty tertiary care hospital,
A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
The hospital was recognised as a Winner (Medium) in the category of Best Academic Institution (Government/Private)
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
Drug Hunter is already relied upon by researchers at more than 200 leading organizations, including Eli Lilly, Biogen, Merck KGaA, Isomorphic Labs, Deerfield Management
This strategic collaboration represents the third clinical trial under Senhwa’s five-year NCI-sponsored cancer research program
ABP-745 is a novel oral therapy with potential applications in cardiovascular and other inflammatory diseases
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Subscribe To Our Newsletter & Stay Updated
